Stromal Vascular Fraction Market: Rising Prevalence of Parkinson's Disease to Fuel Demand
Stromal vascular fraction being a part of stem cell therapy, rising prevalence of chronic ailments including Parkinson's disease, ALS (Amyotrophic Lateral Sclerosis) and diabetes have influenced the growth of the stromal vascular fraction market. According to Parkinson's foundation, in 2017, more than 10 million Parkinson's disease cases were recorded at the global front. This has led to a significant increase in adoption of stromal vascular fraction, in turn pushing the growth of its market. Several insights on the stromal vascular...
View full press release